Literature DB >> 19520808

Activation of Wnt5A signaling is required for CXC chemokine ligand 12-mediated T-cell migration.

Manik C Ghosh1, Gary D Collins, Bolormaa Vandanmagsar, Kalpesh Patel, Margaret Brill, Arnell Carter, Ana Lustig, Kevin G Becker, William W Wood, Chineye D Emeche, Amanda D French, Michael P O'Connell, Mai Xu, Ashani T Weeraratna, Dennis D Taub.   

Abstract

Chemokines mediate the signaling and migration of T cells, but little is known about the transcriptional events involved therein. Microarray analysis of CXC chemokine ligand (CXCL) 12-treated T cells revealed that Wnt ligands are significantly up-regulated during CXCL12 treatment. Real-time polymerase chain reaction and Western blot analysis confirmed that the expression of noncanonical Wnt pathway members (eg, Wnt5A) was specifically up-regulated during CXCL12 stimulation, whereas beta-catenin and canonical Wnt family members were selectively down-regulated. Wnt5A augmented signaling through the CXCL12-CXCR4 axis via the activation of protein kinase C. Moreover, Wnt5A expression was required for CXCL12-mediated T-cell migration, and rWnt5A sensitized human T cells to CXCL12-induced migration. Furthermore, Wnt5A expression was also required for the sustained expression of CXCR4. These results were further supported in vivo using EL4 thymoma metastasis as a model of T-cell migration. Together, these data demonstrate that Wnt5A is a critical mediator of CXCL12-CXCR4 signaling and migration in human and murine T cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19520808      PMCID: PMC2727408          DOI: 10.1182/blood-2008-08-175869

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  26 in total

Review 1.  Wnt signaling in human cancer.

Authors:  Patrice J Morin; Ashani T Weeraratna
Journal:  Cancer Treat Res       Date:  2003

2.  A new secreted protein that binds to Wnt proteins and inhibits their activities.

Authors:  J C Hsieh; L Kodjabachian; M L Rebbert; A Rattner; P M Smallwood; C H Samos; R Nusse; I B Dawid; J Nathans
Journal:  Nature       Date:  1999-04-01       Impact factor: 49.962

Review 3.  The greater chemotactic network for lymphocyte trafficking: chemokines and beyond.

Authors:  Chang H Kim
Journal:  Curr Opin Hematol       Date:  2005-07       Impact factor: 3.284

Review 4.  A novel CXC chemokine PBSF/SDF-1 and its receptor CXCR4: their functions in development, hematopoiesis and HIV infection.

Authors:  T Nagasawa; K Tachibana; T Kishimoto
Journal:  Semin Immunol       Date:  1998-06       Impact factor: 11.130

Review 5.  An intricate Web: chemokine receptors, HIV-1 and hematopoiesis.

Authors:  B Lee; B J Doranz; M Z Ratajczak; R W Doms
Journal:  Stem Cells       Date:  1998       Impact factor: 6.277

6.  Loss of expression of the WNT/beta-catenin-signaling pathway transcription factors lymphoid enhancer factor-1 (LEF-1) and T cell factor-1 (TCF-1) in a subset of peripheral T cell lymphomas.

Authors:  David M Dorfman; Harvey A Greisman; Aliakbar Shahsafaei
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

7.  Diverse transcriptional response of CD4+ T cells to stromal cell-derived factor SDF-1: cell survival promotion and priming effects of SDF-1 on CD4+ T cells.

Authors:  Y Suzuki; M Rahman; H Mitsuya
Journal:  J Immunol       Date:  2001-09-15       Impact factor: 5.422

Review 8.  CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion.

Authors:  Magda Kucia; Kacper Jankowski; Ryan Reca; Marcin Wysoczynski; Laura Bandura; Daniel J Allendorf; Jin Zhang; Janina Ratajczak; Mariusz Z Ratajczak
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

9.  Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma.

Authors:  Ashani T Weeraratna; Yuan Jiang; Galen Hostetter; Kevin Rosenblatt; Paul Duray; Michael Bittner; Jeffrey M Trent
Journal:  Cancer Cell       Date:  2002-04       Impact factor: 31.743

10.  Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation.

Authors:  Lilia Topol; Xueyuan Jiang; Hosoon Choi; Lisa Garrett-Beal; Peter J Carolan; Yingzi Yang
Journal:  J Cell Biol       Date:  2003-09-01       Impact factor: 10.539

View more
  27 in total

1.  Down-regulation of homeobox genes MEIS1 and HOXA in MLL-rearranged acute leukemia impairs engraftment and reduces proliferation.

Authors:  Kira Orlovsky; Alexander Kalinkovich; Tanya Rozovskaia; Elias Shezen; Tomer Itkin; Hansjuerg Alder; Hatice Gulcin Ozer; Letizia Carramusa; Abraham Avigdor; Stefano Volinia; Arthur Buchberg; Alex Mazo; Orit Kollet; Corey Largman; Carlo M Croce; Tatsuya Nakamura; Tsvee Lapidot; Eli Canaani
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

2.  Chemical suppression of specific C-C chemokine signaling pathways enhances cardiac reprogramming.

Authors:  Yijing Guo; Ienglam Lei; Shuo Tian; Wenbin Gao; Karatas Hacer; Yangbing Li; Shaomeng Wang; Liu Liu; Zhong Wang
Journal:  J Biol Chem       Date:  2019-04-25       Impact factor: 5.157

Review 3.  Striking the target in Wnt-y conditions: intervening in Wnt signaling during cancer progression.

Authors:  Tura C Camilli; Ashani T Weeraratna
Journal:  Biochem Pharmacol       Date:  2010-03-06       Impact factor: 5.858

4.  Host Wnt5a Potentiates Microenvironmental Regulation of Ovarian Cancer Metastasis.

Authors:  Marwa Asem; Allison M Young; Carlysa Oyama; Alejandro Claure De La Zerda; Yueying Liu; Jing Yang; Tyvette S Hilliard; Jeffery Johnson; Elizabeth I Harper; Ian Guldner; Siyuan Zhang; Toni Page-Mayberry; William J Kaliney; M Sharon Stack
Journal:  Cancer Res       Date:  2020-01-13       Impact factor: 12.701

5.  Separate and distinctive roles for Wnt5a in tongue, lingual tissue and taste papilla development.

Authors:  Hong-Xiang Liu; Ann S Grosse; Ken Iwatsuki; Yuji Mishina; Deborah L Gumucio; Charlotte M Mistretta
Journal:  Dev Biol       Date:  2011-10-15       Impact factor: 3.582

Review 6.  Hear the Wnt Ror: how melanoma cells adjust to changes in Wnt.

Authors:  Michael P O'Connell; Ashani T Weeraratna
Journal:  Pigment Cell Melanoma Res       Date:  2009-08-25       Impact factor: 4.693

7.  Wnt5a promotes inflammatory responses via nuclear factor κB (NF-κB) and mitogen-activated protein kinase (MAPK) pathways in human dental pulp cells.

Authors:  Yuan Zhao; Chen-Lin Wang; Rui-Min Li; Tian-Qian Hui; Ying-Ying Su; Quan Yuan; Xue-Dong Zhou; Ling Ye
Journal:  J Biol Chem       Date:  2014-07-25       Impact factor: 5.157

Review 8.  Wnt5a: a player in the pathogenesis of atherosclerosis and other inflammatory disorders.

Authors:  Pooja M Bhatt; Ramiro Malgor
Journal:  Atherosclerosis       Date:  2014-09-03       Impact factor: 5.162

Review 9.  The Wnts of change: How Wnts regulate phenotype switching in melanoma.

Authors:  Marie R Webster; Curtis H Kugel; Ashani T Weeraratna
Journal:  Biochim Biophys Acta       Date:  2015-11-04

Review 10.  Wnt your brain be inflamed? Yes, it Wnt!

Authors:  Bianca Marchetti; Stefano Pluchino
Journal:  Trends Mol Med       Date:  2013-01-09       Impact factor: 11.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.